Brief: Lexicon Pharmaceuticals- Entered Into Open Market Sale Deal
29/12/2023 23:26
Dec 29(Reuters) - Lexicon Pharmaceuticals Inc LXRX.O :
* LEXICON PHARMACEUTICALS- ENTERED INTO OPEN MARKET SALE
DEAL, MAY
OFFER AND SELL, FROM TIME TO TIME FOR SALES PRICE OF UP TO $75
MILLION
* LEXICON PHARMACEUTICALS INC- INTENDS TO USE THE NET
PROCEEDS
FROM ANY OFFERINGS TO FUND THE COMMERCIAL LAUNCH OF INPEFA
Further company coverage: LXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview